Literature DB >> 2566634

Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization.

M Honda1, K Kitamura, K Matsuda, Y Yokota, N Yamamoto, R Mitsuyasu, J C Chermann, T Tokunaga.   

Abstract

By using a fluorescence sandwich ELISA, elevated IL-2R levels were detected in the sera from both HIV-infected hemophiliacs and other HIV-infected patients. The serum IL-2R levels were reflective of the classification of HIV-induced diseases by the Centers for Disease Control. Moreover, the IL-2R levels were negatively correlated most prominently with CD4 cell counts, with lymphocyte counts, and with a decrease in the CD4-CD8 ratio but not with either WBC counts or B cell counts. As striking elevations of serum IL-2R were noted in AIDS patients with group IVD infection, the serum IL-2R was purified sequentially by using size-exclusion HPLC, high-pressure chromatofocusing, and H48 affinity HPLC. The isoelectric point values of IL-2R were separated into 4.2 and 3.8, whereas the Mr was determined to be only 45 kDa by immunoprecipitation with H48 antibody followed by SDS-PAGE. However, production of cellular and supernatant IL-2R was not elevated in PBMC of patients with AIDS or in any of the 19 HIV-I- or HIV-II-infected cell line cells. In contrast, PBMC from patients with adult T cell leukemia and cell line cells that expressed human T cell lymphotropic virus -I or -II produced soluble IL-2R, constitutively. The mechanisms by which serum levels of IL-2R might be elevated in HIV-infected patients are discussed in comparison with that in adult T cell leukemia patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566634

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.

Authors:  S Horiuchi; Y Koyanagi; Y Tanaka; M Waki; A Matsumoto; Y W Zhou; M Yamamoto; N Yamamoto
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Serum-soluble interleukin-2 receptor levels before and after surgical treatment for Graves' disease.

Authors:  S Murakami; A Kobayashi; K Kuma; H Murai; Y Okamura; A Satomi; K Ishida
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.

Authors:  M Weiss; M Martignoni; T Petropoulou; B Sölder; B H Belohradsky
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

4.  3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.

Authors:  H Ohnota; Y Okada; H Ushijima; T Kitamura; K Komuro; T Mizuochi
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice.

Authors:  R Fernandez-Botran; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.

Authors:  I Kurane; B L Innis; S Nimmannitya; A Nisalak; A Meager; J Janus; F A Ennis
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.

Authors:  K Mitsuyama; A Toyonaga; E Sasaki; O Ishida; H Ikeda; O Tsuruta; K Harada; H Tateishi; T Nishiyama; K Tanikawa
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.

Authors:  S Sawada; H Hashimoto; S Iijma; Y Tokano; Y Matsukawa; M Takei; H Ishikawa; H Kang; K Tomura; K Mitamura
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

10.  Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

Authors:  I L Noronha; V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.